Gaucher disease (GD), deficiency of acid glucosylceramidase (GlcCer-ase) is characterized by deficient degradation of beta-glucosylceramide (GlcCer). It is well known that, in GD, the lysosomal accumulation of uncleaved GlcCer is limited to macrophages, which are gradually converted to storage cells with well known cytology--Gaucher cells (GCs). On the basis of previous studies of the disorder and of a comparison with other lysosomal enzymopathies affecting degradation of the GlcCer-based glycosphingolipid series, it is hypothesized that in other cell types (i.e. non-macrophage cells) the uncleaved GlcCer, in GlcCer-ase deficiency, is transferred to other cell compartments, where it may be processed and even accumulated to various degrees. The consequence of the abnormal extralysosomal load may differ according to the cell type and compartment targeted and may be influenced by genetically determined factors, by a number of acquired conditions, including the current metabolic situation. The sequelae of the uncleaved GlcCer extralysosomal transfer may range from probably innocent or positive stimulatory, to the much more serious, in which it interferes with a variety of cell functions, and in extreme cases, can lead to cell death. This alternative processing of uncleaved GlcCer may help to explain tissue alterations seen in GD that have, so far, resisted explanation based simply on the presence of GCs. Paralysosomal alternative processing may thus go a long way towards filling a long-standing gap in the understanding of the molecular pathology of the disorder. The impact of this alternative process will most likely be inversely proportional to the level of residual GlcCer-ase activity. Lysosomal sequestration of GlcCer in these cells is either absent or in those exceptional cases where it does occur, it is exceptional and rudimentary. It is suggested that paralysosomal alternative processing of uncleaved GlcCer is the main target for enzyme replacement therapy. The mechanism responsible for GlcCer transfer remains to be elucidated. It may also help in explaining the so far unclear origin of glucosylsphingosine (GlcSph) and define the mutual relation between these two processes.

Institute of Inherited Metabolic Disorders Charles University Prague 1st Faculty of Medicine and University Hospital Bldg D Division B Ke Karlovu 2 128 08 Prague 2 Czech Republic

See more in PubMed

Mol Genet Metab. 2003 Jun;79(2):104-9 PubMed

Baillieres Clin Haematol. 1997 Dec;10(4):657-89 PubMed

Acta Pathol Jpn. 1990 Jun;40(6):425-30 PubMed

Cardiology. 1985;72(3):144-6 PubMed

J Lipid Res. 2002 Aug;43(8):1293-302 PubMed

J Bone Miner Metab. 2002;20(1):34-8 PubMed

J Clin Invest. 1995 Jun;95(6):2903-9 PubMed

Clin Genet. 2001 May;59(5):360-3 PubMed

J Perinatol. 2005 May;25(5):356-8 PubMed

J Neurosci Res. 1996 Feb 1;43(3):365-71 PubMed

Obstet Gynecol. 1993 May;81(5 ( Pt 2)):842-4 PubMed

Biochim Biophys Acta. 1993 Mar 24;1181(1):55-62 PubMed

Sao Paulo Med J. 2002 May 2;120(3):90-2 PubMed

J Pediatr. 2003 Feb;142(2):209-10 PubMed

Am J Ophthalmol. 2005 Feb;139(2):359-62 PubMed

Clin Genet. 2003 Oct;64(4):269-81 PubMed

Mol Med. 2002 May;8(5):247-50 PubMed

Acta Neurol Scand. 1992 Dec;86(6):609-15 PubMed

Acta Neuropathol Suppl. 1981;7:208-10 PubMed

Am J Med. 1978 Aug;65(2):352-60 PubMed

Biochim Biophys Acta. 1979 Feb 1;582(3):423-33 PubMed

J Pediatr. 2001 Jan;138(1):137-9 PubMed

Biochim Biophys Acta. 2004 Oct 11;1685(1-3):8-13 PubMed

Virchows Arch A Pathol Pathol Anat. 1973;360(1):27-32 PubMed

Medicine (Baltimore). 1985 Sep;64(5):310-22 PubMed

J Clin Invest. 1993 May;91(5):1909-17 PubMed

J Clin Invest. 1994 Mar;93(3):1288-92 PubMed

Neurochem Res. 1999 Feb;24(2):199-205 PubMed

Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15 PubMed

Clin Neuropathol. 1990 Nov-Dec;9(6):310-3 PubMed

Am J Med Genet A. 2003 Jul 30;120A(3):338-44 PubMed

Arch Pathol Lab Med. 1985 Jan;109(1):82-4 PubMed

Neurobiol Dis. 2003 Dec;14(3):595-601 PubMed

Biochim Biophys Acta. 1982 May 7;687(2):195-203 PubMed

Neuropediatrics. 2005 Jun;36(3):171-80 PubMed

Virchows Arch B Cell Pathol. 1977 Dec 30;26(2):133-8 PubMed

Biochemistry. 1969 Feb;8(2):506-12 PubMed

J Clin Invest. 1994 Apr;93(4):1756-64 PubMed

Blood Cells Mol Dis. 2005 Sep-Oct;35(2):259-67 PubMed

Arch Pathol Lab Med. 1977 May;101(5):255-9 PubMed

J Biol Chem. 1985 Feb 25;260(4):2295-300 PubMed

Neurochem Res. 1989 Sep;14(9):899-903 PubMed

Neurobiol Dis. 2005 Feb;18(1):83-8 PubMed

Lipids. 1988 May;23(5):508-10 PubMed

Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):331-3 PubMed

Mol Chem Neuropathol. 1995 Feb-Apr;24(2-3):179-92 PubMed

J Biol Chem. 1991 Dec 5;266(34):22968-74 PubMed

J Fr Ophtalmol. 1992;15(3):185-90 PubMed

J Pharmacol Exp Ther. 2004 Feb;308(2):705-11 PubMed

Philos Trans R Soc Lond B Biol Sci. 2003 May 29;358(1433):869-73 PubMed

J Inherit Metab Dis. 2001;24 Suppl 2:106-21; discussion 87-8 PubMed

J Biol Chem. 1980 May 25;255(10):4463-7 PubMed

Eur J Pediatr. 1989 Oct;149(1):31-9 PubMed

Pediatrics. 1995 Oct;96(4 Pt 1):629-37 PubMed

J Clin Invest. 2002 May;109(9):1215-21 PubMed

Ann Neurol. 1988 Mar;23(3):300-3 PubMed

Am J Pediatr Hematol Oncol. 1990 Spring;12(1):74-6 PubMed

Pediatr Res. 1983 May;17(5):344-8 PubMed

Physiol Rev. 2001 Oct;81(4):1689-723 PubMed

J Biol Chem. 1999 Jul 30;274(31):21673-8 PubMed

Am J Med. 2002 Aug 1;113(2):112-9 PubMed

J Biol Chem. 1991 Nov 5;266(31):20907-12 PubMed

Hum Mol Genet. 2001 Apr 15;10(9):927-40 PubMed

Arch Pathol. 1967 Jun;83(6):513-26 PubMed

J Biochem. 1980 Dec;88(6):1765-72 PubMed

Biochim Biophys Acta. 1982 Sep 14;712(3):453-63 PubMed

Pathol Res Pract. 1989 Sep;185(3):293-328 PubMed

Acta Neuropathol. 1988;75(4):385-90 PubMed

J Biol Chem. 1975 May 25;250(10):3966-71 PubMed

Glycoconj J. 2004;21(6):315-27 PubMed

Blood Cells Mol Dis. 2005 May-Jun;34(3):197-200 PubMed

Am J Cardiol. 1983 Sep 1;52(5):654 PubMed

Blood. 2000 Sep 1;96(5):1969-78 PubMed

Hum Mol Genet. 2005 Aug 15;14(16):2387-98 PubMed

Arch Dis Child. 1991 May;66(5):667 PubMed

Clin Chem Lab Med. 2002 Jan;40(1):52-5 PubMed

Eur J Haematol. 2003 May;70(5):273-81 PubMed

Int J Biochem Cell Biol. 2005 Nov;37(11):2310-20 PubMed

Cell Mol Life Sci. 2002 Apr;59(4):694-707 PubMed

Mol Genet Metab. 2004 Jul;82(3):192-207 PubMed

Am J Pathol. 2003 Nov;163(5):2093-101 PubMed

J Biol Chem. 1998 Oct 9;273(41):26522-7 PubMed

Am J Med Genet. 2002 May 15;109(4):328-31 PubMed

Cancer. 1984 Jul 15;54(2):312-4 PubMed

J Pathol Bacteriol. 1956 Jul;72(1):121-31 PubMed

Biochemistry. 1984 Dec 18;23(26):6498-505 PubMed

Mol Genet Metab. 2002 Sep-Oct;77(1-2):91-8 PubMed

Semin Cell Dev Biol. 2004 Aug;15(4):417-31 PubMed

Nature. 1992 Jun 4;357(6377):407-10 PubMed

Mol Cell. 2004 Sep 10;15(5):753-66 PubMed

Biochem J. 2003 Nov 1;375(Pt 3):561-5 PubMed

FASEB J. 2002 Nov;16(13):1814-6 PubMed

Br J Haematol. 2005 Apr;129(2):178-88 PubMed

Lab Invest. 2003 Mar;83(3):397-408 PubMed

Acta Paediatr Suppl. 2005 Mar;94(447):69-75; discussion 57 PubMed

Br J Radiol. 2002;75 Suppl 1:A2-12 PubMed

Pediatr Res. 2000 Aug;48(2):233-7 PubMed

J Biochem. 1994 Sep;116(3):704-10 PubMed

Lab Invest. 1988 May;58(5):590-8 PubMed

Pediatr Res. 1992 Oct;32(4):494-8 PubMed

J Med Genet. 2000 Nov;37(11):E40 PubMed

Mol Genet Metab. 2002 Aug;76(4):262-70 PubMed

Acta Neuropathol. 1991;82(2):152-7 PubMed

Am J Clin Pathol. 2004 Sep;122(3):359-69 PubMed

Fetal Pediatr Pathol. 2005 Jul-Oct;24(4-5):205-22 PubMed

Abnormal nonstoring capillary endothelium: a novel feature of Gaucher disease. Ultrastructural study of dermal capillaries

Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process